Genmab | GEN - Equity Capital And Reserves

Stock Price
2,050.00
Daily Change
-47.00 -2.24%
Monthly
1.99%
Yearly
46.17%
Q1 Forecast
1,920.90

Genmab reported DKK5.3B in Equity Capital and Reserves for its fiscal quarter ending in June of 2025.





Equity Capital And Reserves Change Date
Agios Pharmaceuticals USD 1.28B 85.22M Sep/2025
Almirall EUR 1.46B 25.28M Jun/2025
Amarin USD 458.89M 6.03M Sep/2025
Amgen USD 9.62B 2.19B Sep/2025
argenx SE USD 6.1B 597.47M Jun/2025
AstraZeneca USD 45.89B 1.17B Sep/2025
Bayer EUR 29.7B 799M Sep/2025
BioMarin Pharmaceutical USD 6.06B 29.6M Sep/2025
Demant DKK 9.84B 446M Dec/2025
Exelixis USD 2.16B 127.16M Sep/2025
Fresenius Medical Care EUR 12.95B 1.38B Sep/2025
Galapagos EUR 2.45B 196.86M Sep/2025
Genmab DKK 5.3B 6M Jun/2025
GlaxoSmithKline GBP 16.15B 1.79B Sep/2025
GN Store Nord DKK 10.54B 95M Sep/2025
GRIFOLS EUR 5.18B 2.42B Sep/2025
Hikma Pharmaceutical USD 2.55B 230M Jun/2025
Insmed USD 945.57M 304.16M Sep/2025
Lonza CHF 9.33B 23M Dec/2024
Merck EUR 28.94B 677M Sep/2025
Novartis USD 44.75B 2.7B Sep/2025
Regeneron Pharmaceuticals USD 31.26B 299.1M Dec/2025
Roche Holding CHF 33.8B 758M Dec/2025
Sanofi EUR 71.71B 1.55B Dec/2025
UCB EUR 10.03B 1.08B Dec/2024